AMP Global - Scott

Hamish S. Scott, PhD

Hamish S. Scott has a long standing track record is in the application of genetic and genomic technologies for genetic disease discovery, understanding, diagnoses and treatment. He did his PhD and first post-doc at the Adelaide Women’s and Children’s Hospital followed by 5 years at the University of Geneva Medical School, Switzerland where joined junior faculty. He returned to Australia at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne for 8 years.
Since 2008, he has been head of the Department of Genetics and Molecular Pathology at the Centre for Cancer Biology, an alliance between SA Pathology & the University of South Australia. He has transformed his department from being largely diagnostic (~40 people), to being a dynamic academic/diagnostic department integrated with the CCB ACRF Cancer Genome Facility (of which he is co-director). Including the genome facility, his department now has ~35 full-time research personnel and is active in student placements and clinical trials. He has been central to the introduction of new technologies for both somatic and germline genotyping for improved diagnoses and treatment (personalized medicine) including national and international firsts for which his team has won several prizes. He is a national and international leader in identification of germline mutations in families and patients that predispose them to blood cancers and somatic mutations to monitor their disease. He is a co-leader of a national study to identify genetic causes of perinatal death and for molecular testing for the Australian Genomic Cancer Medicine Centre precision oncology clinical trials. He has studied and modelled human genes, alleles and diseases in vitro, ex vivo and in vivo.

Leave a Reply

Your email address will not be published.